Please assess the completion status of the following clinical trial:

Trial Title: Safety and Effectiveness of Kovacaine Nasal Spray for Dental Anesthesia

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: SUPPORTIVE_CARE
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE2
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Male or female between 18 and 65 years of age~* Sufficiently healthy as determined by the investigator to receive the test and control medications and undergo the scheduled dental procedure~* Required an operative restorative procedure on a single maxillary tooth, other than a maxillary second or third molar, with treatment time not expected to exceed 60 minutes~* Could breathe through both nostrils~* Had normal lip, nose, eyelid, and cheek sensations~* Could understand and sign the informed consent document~* Could communicate with the investigator~* Could understand and comply with the requirements of the protocol~Exclusion Criteria:~* Clinically relevant history or presence of respiratory, gastrointestinal, renal, hepatic, hematological, lymphatic, cardiovascular, psychiatric, musculoskeletal, neurologic, genitourinary, infective, inflammatory, immunological, dermatological, or connective tissue disease or disorder or a clinically relevant history or presence of angle-closure glaucoma~* Clinically relevant sinus/nasal surgical history~* Baseline Visual Analog Scale value of \> 36 (or greater than weak) at the treatment site~* Had not had dental work requiring a local anesthetic within the last 24 hours or had taken pain medications within the last 48 hours~* Required prophylactic antibiotics for subacute bacterial endocarditis (infectious endocarditis)~* Allergic to or intolerant of tetracaine, benzocaine, other ester local anesthetics, or p-aminobenzoic acid (PABA), as found in PABA-containing sunscreens~* Allergic to or intolerant of oxymetazoline, epinephrine, or preservatives in their solutions~* Had a current condition, such as nasal congestion or sinus infection, that may have influenced responses to study medications~* History of alcoholism and/or drug abuse~* Had taken a monamine oxidase inhibitor within the past 3 weeks~* Were nursing, pregnant, suspected of being pregnant, or trying to become pregnant (females were required to take a urine pregnancy test to rule out pregnancy)~* Had used any investigational drug and/or participated in any clinical trial within 30 days of baseline

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: t

Study Arms:
- Kovacaine Nasal Spray (Type: EXPERIMENTAL): 3% tetracaine HCL with 0.05% oxymetazoline HCL - Delivered via 3 sprays (100 uL) in each nostril
- Lidocaine Injection (Type: ACTIVE_COMPARATOR): .5 to 1 catridge of 2% lidocaine HCL with 1:100,000 epinephrine

Based on this trial design, predict the completion outcome and termination type (if applicable).